se of Homoeopathic Medicine in the Treatment of Gastroesophageal Reflux Disease.
Phase 2
- Conditions
- Health Condition 1: K21- Gastro-esophageal reflux disease
- Registration Number
- CTRI/2024/05/066693
- Lead Sponsor
- ational Institute of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient suffering from GERD diagnosed clinically and by GERD Questionnaire (GERD Q).
2.Patients aged between 20 to 65 years.
3.Patients of both sexes, all religions, and of different socioeconomic status.
Exclusion Criteria
1.Pregnant and lactating women.
2.Patients who aren’t willing to lifestyle modification.
3.Patients having complications of GERD like dysphagia, food impaction, etc.
4.Patients having any terminal disease condition like cancer, end-stage renal disease, etc.
5.Patients not willing to take part in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare changes in the GERD Health-Related Quality of Life (GERD- HRQL) Questionnaire score in the patient suffering from GERD treated with Individualized Homoeopathic Medicine and Quassia amara-30C over 3 months.Timepoint: baseline and 3 month
- Secondary Outcome Measures
Name Time Method To compare changes in the Perceived Stress Scale (PSS) score in the patient suffering from GERD treated with Individualized Homoeopathic Medicine and Quassia amara-30C over 3 months.Timepoint: Baseline and 3 month